Dr. David Todd Rudman, MD

Dr. Rudman practices at Ascentist Ear Nose And Throat Institute in Merriam, Kansas.

Dr. Rudman's NPI, 1558326199, was assigned on April 18, 2006. Dr. Rudman graduated from University of Missouri School of Medicine in 1995. Dr. Rudman's Kansas license number on file is 04-28631.

Dr. Rudman's primary practice is Ascentist Ear Nose and Throat Institute, at 6815 Frontage Road, Ste B, Merriam, KS 66204. The practice phone is (913) 318-3800.

Dr. Rudman's primary practice is Ascentist Ear Nose And Throat Institute in Merriam, Kansas. Dr. Rudman is also affiliated with Menorah Medical Center. The medical group on file is Ascentist Healthcare. Dmand AI also links Dr. Rudman to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rudman practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rudman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Rudman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Rudman's licenses on file in 3 states: Kansas, Missouri and Ohio.

Dmand AI lists acute sinusitis, chronic ear infection, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Rudman treats.

CMS data shows 2,081 Medicare services from Dr. Rudman across 21 procedure codes in 2024, for 499 Medicare patients. Medicare paid $187,750 for them.

CMS counts 499 Medicare patients who saw Dr. Rudman in 2024. The largest group is 65 to 74, with 245 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rudman's median patient age at 50, with 48% women.

In 2024, Dr. Rudman wrote 818 Medicare Part D claims for 266 patients. 96% of them were for generic drugs. CMS names the drug for 730 of them, across 15 drugs with 11 or more claims each, at $64,522 in total drug cost. In 2023, CMS named 778 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Rudman for performance year 2024, reported as part of a group. Dr. Rudman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rudman as offering telehealth.

Dmand AI links 2 papers to Dr. Rudman. Dr. Rudman's most frequent co-authors are Gregory J. Wiet, MD and Gail E. Besner, MD.

CMS Open Payments shows 452 general payments to Dr. Rudman from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Intuitive Surgical, Inc. paid the most, $7,619.

Dmand AI lists 4 awards for Dr. Rudman, most recently CMS Stage 1 EHR in 2014.

Dr. Rudman graduated from University of Missouri School of Medicine in 1995. Dr. Rudman is a member of NHS and ACS.

Dr. Rudman is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.